A once-yearly intramuscular lenacapavir (Sunlenca) injection was safe and well-tolerated and had higher median levels of ...

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

New data suggest that lenacapavir delivered just once per year could be as effective for HIV prevention as the twice-yearly ...

To manage risk, investors should diversify their stock portfolio across industries and this could be the stock to study in the pharmaceutical sector for the long haul.

NORTHAMPTON, MA / ACCESS Newswire / March 14, 2025 / In recognition of Women's History Month, our Identity + Innovation spotlight features Devi SenGupta. Hear how Devi's background has shaped her ...

Your FREE insider update on the biggest news stories and investing trends, delivered midday TheChart of the Day belongs to ...

Gilead has reported results for a once-yearly intramuscular injection that show blood concentrations of lenacapavir exceeded ...

Consumer sentiment fell in the U.S. as citizens reacted to President Donald Trump’s intensifying trade war. A survey conducted by the ...

Biogen (BIIB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Takeda is sharpening its oncology focus amid an R&D revamp. Sun Pharma will acquire Checkpoint Therapeutics and an ...

The company granted stock options to purchase an aggregate of 157,150 shares of Nurix common stock and restricted stock unit awards (RSUs) representing an aggregate of 107,500 shares of Nurix common ...

Cantor Fitzgerald dropped their FY2025 earnings per share (EPS) estimates for shares of Tango Therapeutics in a research report issued to clients and investors on Monday, March 10th. Cantor Fitzgerald ...